An unusual and difficult diagnosis of intestinal obstruction: The abdominal cocoon. Case report and review of the literature

Since publication of our article, "An unusual and difficult diagnosis of intestinal obstruction: The abdominal cocoon. Case report and review of the literature." World J Emerg Surg. 2006, 1: 8 we believe that the case mentioned should have been described as a 'peritoneal encapsulation' rather than 'abdominal cocoon' as concluded in the original publication

An unusual and difficult diagnosis of intestinal obstruction: The abdominal cocoon. Case report and review of the literature

Abdominal cocoon is a rare cause of intestinal obstruction. The abdominal cocoon is probably a developmental abnormality, largely asymptomatic, and is found incidentally at laparotomy or autopsy. Pre-operative diagnosis cannot be often made correctly. This rare entity of intestinal obstruction has been described in the whole literature as a thick fibrotic sac covering the small bowel partially or completely. The etiology of abdominal cocoon is unknown and most often it is found in adolescent girls from tropical or subtropical countries. Complete recovery is generally expected after the removal of the membrane surgically. This paper reports a male patient who has had intestinal obstruction symptoms and has per-operatively been diagnosed as abdominal cocoon

Rectal Dieulafoy Lesions: A Rare Etiology of Chronic Lower Gastrointestinal Bleeding

Dieulafoy lesion is rarely seen, yet it can be life-threatening. This lesion makes up to 1-2% of gastrointestinal bleedings and must definitely be considered in gastrointestinal bleedings whose source cannot be identified. In this case study, the 75-year-old woman was suffering from active, fresh, and massive rectal bleeding. Colonoscopy was applied in order to find out the source of bleeding. In the typical endoscopic appearance of the lesion a single round mucosal defect in the rectum and arterial bleeding were observed. To procure hemostasis, epinephrine was injected into the lesion and the bleeding vein was sutured

Case Report Rectal Dieulafoy Lesions: A Rare Etiology of Chronic Lower Gastrointestinal Bleeding

Dieulafoy lesion is rarely seen, yet it can be life-threatening. This lesion makes up to 1-2% of gastrointestinal bleedings and must definitely be considered in gastrointestinal bleedings whose source cannot be identified. In this case study, the 75-year-old woman was suffering from active, fresh, and massive rectal bleeding. Colonoscopy was applied in order to find out the source of bleeding. In the typical endoscopic appearance of the lesion a single round mucosal defect in the rectum and arterial bleeding were observed. To procure hemostasis, epinephrine was injected into the lesion and the bleeding vein was sutured

Castleman’s disease as cervical mass: a report of three cases and review of the literature

La malattia di Castleman, patologia rara descritta nel 1956 da Castleman, è caratterizzato da iperplasia benigna linfonodale di collo, mediastino, addome e altre regioni. L'etiopatogenesi della malattia è sconosciuta. Può essere classificata in tre istotipi: ialino-vascolare, plasma-cellulare e misto. Riportiamo tre casi di malattia di Castleman (tipo ialino-vascolare) in tre donne, manifestatasi con linfonodopatia cervicale unilaterale. Nessuno delle pazienti ha sviluppato recidiva locale o a distanza durante il followup postoperatorio

A Case of Adrenal Incidentaloma: Diagnosed Pheochromocytoma during Uncontrolled Diabetes Mellitus Follow-up [Bir Adrenal Insidentaloma Olgusu: Kontrolsuz Diabetes Mellitus Takibinde Feokromositoma Tanisi]

Adrenal incidentalomas are serendipitously discovered by radiologic examination. Whether malignant mass and hormonal activity are two basic questions that need to be explained. Obtained radiological imaging features are very important and they are also guiding for diagnosis. Diagnostic biopsy of the lesion can be done but not used in routine. Although the majority of lesions in terms of hormonal activity are nonfunctional, patients can have different signs and symptoms. Therefore, they cant attract the attention of the clinician until incidentally detected mass. Despite treatment modifications, we can not be achieved diabetic control in our case. We detected adrenal incidentaloma during follow-up, we are faced with an asymptomatic cases of pheochromocytoma. Surgical treatment was provided with both laboratory and clinical stabilization of the patients. [Med-Science 2016; 5(2.000): 683-92

Preoperative Serum Levels of Soluble Endoglin for Prediction of Recurrence in Stage III Colorectal Cancer Patients

Background: To evaluate the clinical usefulness of serum levels of soluble form of endoglin in stage III colorectal adenocarcinomas (CRC) patients for detection of recurrence. Methods: The case-control study consisted of 80 stage III CRC patients who underwent surgery with curative intent and 70 age-and sex-matched healthy volunteers. Serum levels of soluble form of endoglin (sol-end) were measured in both groups. Also, predictive factors of recurrence were evaluated using multivariate analyses. Results: Serum levels of sol-end in stage III CRC patients were significantly higher than those in controls. There was not a significant association between serum levels of sol-end and clinicopathological features in CRC patients. Multivariate regression analysis showed the LNR (hazard ratio, 2.54; 95% CI, 1.46–4.34; p < 0.001), to be significant independent factors to estimate local recurrence in stage III CRC patients. Conclusion: Preoperative serum levels of sol-end do not seem useful as a marker for detection of recurrence in stage III CRC patients

Are colon neoplastic lesions associated with stomach helicobacter pylori infection?

A number of previous studies have shown that there is a correlation between Helicobacter Pylori (H. Pylori) and colorectal neoplasia. However, other studies could not prove whether there is a relation between the H. Pylori infection and the development of neoplastic polyploidy lesions in the colon. The aim of this study was to examine whether there is an in increase in the development of neoplastic lesions in the colon depending on the H. Pylori infection. In this case controlled retrospective study, patients who underwent both endoscopy and colonoscopy at the endoscopy unit of our hospital between January 2012 and January 2013 were evaluated. At colonoscopy, patients without any pathology or whose colon mucosa pathologies were reported as “nonspecific colon mucosa” were classified as the first group (n = 85), and those with one or more than one polyps as the second group (n = 75). The groups were compared in terms of the presence and intensity of H. Pylori, and severity of inflammatory activity and intestinal metaplasia. The results of the two groups were analogous with regard to H. Pylori positivity (p&gt;0.05). No statistical difference was observed between the two groups with respect to H. Pylori intensity and severity of inflammatory activity in the H. Pylori positive patients (p&gt;0.05). In conclusion, no relation between the presence of H. Pylori and the formation of polyp in the colon was found. </p

Diagnostic Significance of Serum Eotaxin-1 Level in Gastric Cancer Patients

Introduction. Gastric cancer is the second cause of cancer-related deaths worldwide. Delayed diagnosis leads to high mortality rates. Eotaxin-1 was originally discovered as an eosinophil-selective chemoattractant and may play a role in a number of chronic inflammatory diseases, cancer, and other gastrointestinal disorders. The aim of this study was to analyse diagnostic and prognostic significance of serum eotaxin-1 (s-eotaxin-1) levels in gastric cancer. Methods. Sixty gastric cancer patients and 69 healthy subjects were included into the study. S-eotaxin-1 levels were compared with clinicopathological features and outcomes in gastric cancer. Results. Serum levels of eotaxin-1 in gastric cancer patients were significantly higher than controls (74.51 +/- 16.65 pg/mL versus 16.79 +/- 5.52 pg/mL, respectively (P < 0.001)). The s-eotaxin-1 levels did not differ significantly with histopathological grade, tumor-node-metastasis (TNM) stage, tumor localization, lymph node metastases, positive lymph node ratio, size, perineural and perivascular invasion. So there is no relationship found between s-eotaxin-1 level and prognosis. Conclusion. S-eotaxin-1 levels may be used as an easily available biomarker for gastric cancer risk and may alert physicians for early diagnosis. Due to the limited number of patients included in this study, larger cohort studies are warranted to validate the diagnostic value of s-eotaxin-1 level in gastric cancer